Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment

In a recent study published in the journal of Genes & Diseases, Research team led by Lu explores the potential for the use of FDA-approved hypertension and EMA-approved cough medicines to revolutionize cancer treatment.

Leave A Comment

Your email address will not be published. Required fields are marked *